5
May 2026
Silicosis remains widespread among mineral miners worldwide
Researchers from National Jewish Health conducted what is believed to be the largest systematic review of silicosis in mineral miners.
5
May 2026
Researchers from National Jewish Health conducted what is believed to be the largest systematic review of silicosis in mineral miners.
5
May 2026
A non-toxic coating developed by researchers at University of Toronto Engineering prevents proteins from sticking to surfaces - potentially offering a new tool in the fight against hospital-acquired infections.
5
May 2026
Researchers at the University of Toronto have identified a protein from the quagga mussel that can stick to surfaces underwater, even though it lacks a chemical feature long thought to be essential for this kind of adhesion.
5
May 2026
Researchers at the University of Toronto's Institute of Biomedical Engineering have developed a new method to mature lab-grown heart cells, so they more closely resemble adult human heart tissue.
5
May 2026
Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 protein only after treatment with chemotherapy, allowing them to survive by becoming more invasive and leading to treatment resistance with eventual relapse in patients with small cell lung cancer (SCLC).
5
May 2026
A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 suggests that both very low and very high resting heart rates are linked with an increased risk of stroke.
5
May 2026
A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 shows that after decades of decline, stroke incidence is rising again, driven by higher rates in some ethnic minority populations and concentrated among socioeconomically disadvantaged groups.
5
May 2026
The new focus on manned missions to the moon and Mars presents countless pressing challenges, including keeping humans alive in hostile environments.
5
May 2026
New research from the George Washington University School of Medicine and Health Sciences provides evidence that sensitive skin syndrome (SSS) is biologically distinct from rosacea, helping clarify a long-standing debate in dermatology and potentially guiding more targeted treatment approaches.
5
May 2026
Researchers at City of Hope® and TGen (part of City of Hope) have identified a significant correlation between a tumor's "splicing burden" and its clinical response to treatment for metastatic renal cell carcinoma (mRCC).
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more